Document background
The Accelerated Clinical Trial Agreement is designed for situations requiring rapid implementation of clinical research under Danish jurisdiction, such as urgent medical needs, pandemic responses, or breakthrough therapy development. This agreement template streamlines the traditional clinical trial agreement process while maintaining compliance with Danish law, EU Clinical Trials Regulation, and GCP guidelines. It includes provisions for expedited review processes, rapid site activation, accelerated patient recruitment, and streamlined data collection, while ensuring proper safety monitoring and regulatory oversight. The document is particularly relevant for time-sensitive research projects where standard timeline procedures would be inadequate, incorporating specific requirements from the Danish Medicines Agency and local ethics committees. It addresses key aspects such as accelerated budget approval, rapid study drug availability, expedited data reporting, and enhanced safety monitoring protocols.
%20(1).jpg)
